TY - JOUR
T1 - Racial and ethnic differences in the treatment of seriously ill patients
T2 - A comparison of African-American, Caucasian and Hispanic Veterans
AU - Braun, Ursula K.
AU - McCullough, Laurence B.
AU - Beyth, Rebecca J.
AU - Wray, Nelda
AU - Kunik, Mark E.
AU - Morgan, Robert O.
N1 - Funding Information:
Financial support: Braun and this project were supported by a VA HSR&D Research Career Development Award, RCD 02029. Results of this study were presented in part at the presidential poster session of the American Geriatrics Society Meeting in May 2005.
Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2008/9
Y1 - 2008/9
N2 - Background: No national data exist regarding racial/ethnic differences in the use of interventions for patients at the end of life. Objectives: To test whether among 3 cohorts of hospitalized seriously ill veterans with cancer, noncancer or dementia the use of common life-sustaining treatments differed significantly by race/ethnicity. Design: Retrospective cohort study during fiscal years 1991-2002. Patients: Hospitalized veterans >55 years, defined clinically as at high-risk for 6-month mortality, not by decedent data. Measurements: Utilization patterns by race/ethnicity for 5 life-sustaining therapies. Logistic regression models evaluated differences among Caucasians, African Americans and Hispanics, controlling for age, disease severity and clustering of patients within Veterans Affairs (VA) medical centers. Results: Among 166,059 veterans, both differences and commonalities across diagnostic cohorts were found. African Americans received more or the same amount of end-of-life treatments across disease cohorts, except for less resuscitation [OR=0.84 (0.77-0.92), p=0.002] and mechanical ventilation [OR=0.89 (0.85-0.94), p≤0.0001] in noncancer patients. Hispanics were 36% (cancer) to 55% (noncancer) to 88% (dementia) more likely to receive transfusions than Caucasians (p<0.0001). They received similar rates as Caucasians for all other interventions in all other groups, except for 161% higher likelihood for mechanical ventilation in patients with dementia. Increased end-of-life treatments for both minority groups were most pronounced in the dementia cohort. Differences demonstrated a strong interaction with the disease cohort. Conclusions: Differences in level of end-of-life treatments were disease specific and bidirectional for African Americans. In the absence of generally accepted, evidence-based standards for end-of-life care, these differences may or may not constitute disparities.
AB - Background: No national data exist regarding racial/ethnic differences in the use of interventions for patients at the end of life. Objectives: To test whether among 3 cohorts of hospitalized seriously ill veterans with cancer, noncancer or dementia the use of common life-sustaining treatments differed significantly by race/ethnicity. Design: Retrospective cohort study during fiscal years 1991-2002. Patients: Hospitalized veterans >55 years, defined clinically as at high-risk for 6-month mortality, not by decedent data. Measurements: Utilization patterns by race/ethnicity for 5 life-sustaining therapies. Logistic regression models evaluated differences among Caucasians, African Americans and Hispanics, controlling for age, disease severity and clustering of patients within Veterans Affairs (VA) medical centers. Results: Among 166,059 veterans, both differences and commonalities across diagnostic cohorts were found. African Americans received more or the same amount of end-of-life treatments across disease cohorts, except for less resuscitation [OR=0.84 (0.77-0.92), p=0.002] and mechanical ventilation [OR=0.89 (0.85-0.94), p≤0.0001] in noncancer patients. Hispanics were 36% (cancer) to 55% (noncancer) to 88% (dementia) more likely to receive transfusions than Caucasians (p<0.0001). They received similar rates as Caucasians for all other interventions in all other groups, except for 161% higher likelihood for mechanical ventilation in patients with dementia. Increased end-of-life treatments for both minority groups were most pronounced in the dementia cohort. Differences demonstrated a strong interaction with the disease cohort. Conclusions: Differences in level of end-of-life treatments were disease specific and bidirectional for African Americans. In the absence of generally accepted, evidence-based standards for end-of-life care, these differences may or may not constitute disparities.
KW - Intensive care
KW - Race/ethnicity
UR - http://www.scopus.com/inward/record.url?scp=52449097499&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=52449097499&partnerID=8YFLogxK
U2 - 10.1016/S0027-9684(15)31442-5
DO - 10.1016/S0027-9684(15)31442-5
M3 - Article
C2 - 18807433
AN - SCOPUS:52449097499
SN - 0027-9684
VL - 100
SP - 1041
EP - 1051
JO - Journal of the National Medical Association
JF - Journal of the National Medical Association
IS - 9
ER -